|
1
|
Satter EK and High WA: Langerhans cell
histiocytosis: A review of the current recommendations of the
Histiocyte Society. Pediatr Dermatol. 25:291–295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Favara BE, McCarthy RC and Mierau GW:
Histiocytosis X. Hum Pathol. 14:663–676. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lieberman PH, Jones CR, Steinman RM, et
al: Langerhans cell (eosinophilic) granulomatosis. A
clinicopathologic study encompassing 50 years. Am J Surg Pathol.
20:519–552. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Egeler RM and D'Angio GJ: Langerhans cell
histiocytosis. J Pediatr. 127:1–11. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schulze J, Kitz R, Gruttner HP, et al:
Severe isolated pulmonary Langerhans cell histiocytosis in a
6-year-old girl. Eur J Pediatr. 163:320–322. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lajolo C, Campisi G, Deli G, et al:
Langerhans's cell histiocytosis in old subjects: Two rare case
reports and review of the literature. Gerodontology.
29:e1207–e1214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minkov M, Prosch H, Steiner M, et al:
Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer.
45:802–807. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McClain KL: Langerhans cell histiocytosis:
what is the orphan telling us? Hematology (Am Soc Hematol Educ
Program). 84–87. 2004.
|
|
9
|
Isaacs H Jr: Fetal and neonatal
histiocytoses. Pediatr Blood Cancer. 47:123–129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abla O, Egeler RM and Weitzman S:
Langerhans cell histiocytosis: Current concepts and treatments.
Cancer Treat Rev. 36:354–359. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allen CE and McClain KL: Langerhans cell
histiocytosis: a review of past, current and future therapies.
Drugs Today (Barc). 43:627–643. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lau EG, Stepenaskie S, Moran R, et al:
ʻBlueberry muffinʼ rash and large right thigh mass: a unique
presentation of Langerhans cell histiocytosis. Dermatol Online J.
19:185682013.PubMed/NCBI
|
|
13
|
Herwig MC, Wojno T, Zhang Q and
Grossniklaus HE: Langerhans cell histiocytosis of the orbit: Five
clinicopathologic cases and review of the literature. Surv
Opthalmol. 58:330–340. 2013. View Article : Google Scholar
|
|
14
|
Kasper EM, Aguirre-Padilla DH, Alter RY,
et al: Histiocytosis X: Characteristics, behavior and treatments as
illustrated in a case series. Surg Neurol Int. 2:572011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kairouz S, Hashash J, Kabbara W, et al:
Dendritic cell neoplasms: an overview. Am J Hematol. 82:924–928.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi K, Harada M, Kimoto M and Kondo
F: Diagnostic confirmation of Langerhans cell histiocytosis of the
jaws with CD1a immunostaining: a case report. J Oral Maxillofac
Surg. 61:118–122. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valladeau J, Dezutter-Dambuyant C and
Saeland S: Langerin/CD207 sheds light on formation of birbeck
granules and their possible function in Langerhans cells. Immunol
Res. 28:93–107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rizzo FM, Cives M, Simone V, et al: New
insights into the molecular pathogenesis of langerhans cell
histiocytosis. Oncologist. 19:151–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egeler RM, van Halteren AG, Hogendoorn PC,
et al: Langerhans cell histiocytosis: fascinating dynamics of the
dendritic cell-macrophage lineage. Immunol Rev. 234:213–232. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Allen CE, Li L, Peters TL, et al:
Cell-specific gene expression in Langerhans cell histiocytosis
lesions reveals a distinct profile compared with epidermal
Langerhans cells. J Immunol. 184:4557–4567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Annels NE, Da Costa CE, Prins F, et al:
Aberrant chemokine receptor expression and chemokine production by
Langerhans cells underlies the pathogenesis of Langerhans cell
histiocytosis. J Exp Med. 197:1385–1390. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hicks J and Flaitz CM: Langerhans cell
histiocytosis: current insights in a molecular age with emphasis on
clinical oral and maxillofacial pathology practice. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 100:(2 Suppl). 42–66. 2005.
View Article : Google Scholar
|
|
23
|
Bechan GI, Egeler RM and Arceci RJ:
Biology of Langerhans cells and Langerhans cell histiocytosis. Int
Rev Cytol. 254:1–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Filippi P, Badulli C, Cuccia M, et al:
Specific polymorphisms of cytokine genes are associated with
different risks to develop single-system or multi-system childhood
Langerhans cell histiocytosis. Br J Haematol. 132:784–787. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Egeler RM, Annels NE and Hogendoorn PC:
Langerhans cell histiocytosis: a pathologic combination of
oncogenesis and immune dysregulation. Pediatr Blood Cancer.
42:401–403. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chikwava KR, Hunt JL, Mantha GS, et al:
Analysis of loss of heterozygosity in single-system and multisystem
Langerhans' cell histiocytosis. Pediatr Dev Pathol. 10:18–24. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Badalian-Very G, Vergilio JA, Degar BA, et
al: Recurrent BRAF mutations in Langerhans cell histiocytosis.
Blood. 116:1919–1923. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sahm F, Capper D, Preusser M, et al:
BRAFV600E mutant protein is expressed in cells of variable
maturation in Langerhans cell histiocytosis. Blood. 120:e28–e34.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haroche J, Cohen-Aubart F, Emile JF, et
al: Dramatic efficacy of vemurafenib in both multisystemic and
refractory Erdheim-Chester disease and Langerhans cell
histiocytosis harboring the BRAF V600E mutation. Blood.
121:1495–1500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Minkov M: Multisystem Langerhans cell
histiocytosis in children: current treatment and future directions.
Paediatr Drugs. 13:75–86. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Behrman RE, Kliegman RM and Jenson HB:
Class 1 histiocytosesNelson Textbook of Pediatrics. 16th. W.B.
Saunders; Philadelphia, PA: pp. 1570–1572. 2000
|
|
32
|
Jordan MB, McClain KL, Yan X, Hicks J and
Jaffe R: Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells
in Langerhans cell histiocytosis. Pediatr Blood Cancer. 44:251–254.
2005. View Article : Google Scholar : PubMed/NCBI
|
